About source1medicine

THE WHO AND WHAT

A patient-advocacy organization, source1medicine consists of medical healthcare practitioners (HCPs) and education professionals who bring years of clinical and pedagogical experience to an ever-increasing, unmet issue: how every HCP might efficiently sort through the daily onslaught of medical journal articles, lay press journalism, and protocol-therapeutic updates to read only those essentials germane to respective interests and practices.

 

A subscription to source1medicine, in addition to advertising revenue, sponsoring dollars, and fund-raising, helps drive solutions to two other imperatives yet currently significant hurdles:

• a definitive, first-of-its-kind, user-intuitive search engine for FDA-listed clinical trials

• s1m’s overarching goal to assist patients who financially qualify by need with accessibility to, transportation to, and accommodations at those clinical trials

 

THE HOW AND WHEN

source1medicine offers HCPs one more email—sounds counterintuitive—which elegantly compresses an overwhelmed inbox with a streamlined, indispensable, one-click option. Curated for the reader’s self-described interests and delivered Monday through Friday, our email and webpage display timely reads per varied content bucket, inform on the amount of reading time required for each article through a respective word count, and synopsize that article with a succinct abstract helping the reader decide whether to dive deeper. 

 

AND THE WHY

Empowering the patient-HCP connection, s1m, a Princeton, NJ-based non-profit, evolved from the goal to assist patients and caregivers struggling to find solutions—and the needed gift of hope therein— by facilitating a first-of-its-kind, user-friendly, intuitive accessibility to clinical trials information through their HCP, their HCP’s staff, or by themselves without sifting through the learning curves and confusing miasma of the presently available access portals. 

 

The s1m mechanism of action:

• prioritizes the HCP’s needed efficiency in the day’s myriad readings

• provides access to our indispensable clinical trial user-efficient search engine and repository

• creates opportunities for clinical trial accessibility for patients, whether through financial assistance, awareness, or both